Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer

Ovarian cancer therapy may help treat patients with aggressive pancreatic cancer

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Scientists develop integrated system for early diagnosis of diseases using wearable monitors

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Aravive Biologics demonstrates proof-of-mechanism for AVB-S6-500 in ongoing phase 1 study

Scientists identify mutation that makes tumor cells resistant to breast and ovarian cancer drug

Scientists identify mutation that makes tumor cells resistant to breast and ovarian cancer drug

Research findings could lead to new therapies to curb ovarian cancer metastasis

Research findings could lead to new therapies to curb ovarian cancer metastasis

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Preclinical study suggests ARID1a mutations may help predict immunotherapy success

Targeted 'click-to-release' chemotherapy leads to potent antitumor activity in mice

Targeted 'click-to-release' chemotherapy leads to potent antitumor activity in mice

Study shows patients in major prostate cancer study are more likely to die than real-world patients

Study shows patients in major prostate cancer study are more likely to die than real-world patients

Studies show hemp's potential for treating ovarian cancer

Studies show hemp's potential for treating ovarian cancer

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

Low-cost blood test for multiple myeloma can deliver same diagnostic information as bone biopsy

New study maps links between 625 genes and different chemotherapy treatments

New study maps links between 625 genes and different chemotherapy treatments

Ludwig scientists develop and test individualized ovarian cancer vaccine

Ludwig scientists develop and test individualized ovarian cancer vaccine

The Rivkin Center announces $1.185 million in ovarian cancer research grants for 2018

The Rivkin Center announces $1.185 million in ovarian cancer research grants for 2018

New cancer vaccine yields promising results in clinical study

New cancer vaccine yields promising results in clinical study

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Researchers develop novel approach to fighting ovarian cancer

Researchers develop novel approach to fighting ovarian cancer

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

FDA-approved inhibitors could be repurposed to target ARID1A-mutant ovarian cancers

Without context or cushion, Do online medical results make sense?

Without context or cushion, Do online medical results make sense?

Obesity linked to increased DNA damage in breast epithelium of BRCA mutation carriers

Obesity linked to increased DNA damage in breast epithelium of BRCA mutation carriers

Ludwig researchers extend potential for personalized immunotherapy to ovarian cancer, other tumors

Ludwig researchers extend potential for personalized immunotherapy to ovarian cancer, other tumors